- Advertisement -
- A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before symptoms or signs appear on brain scans.
- Higher pTau217 levels in cognitively healthy adults were linked to faster buildup of amyloid and tau proteins, as well as future cognitive decline.
- Changes in pTau217 often occurred before…

